Market Mirror Wire

IMARC Group, a leading market research company, has recently released a report titled “ Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 .” The study provides a detailed analysis of the industry, including the global connected drug delivery devices market share , size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. How Big is the Connected Drug Delivery Devices Market? The global connected drug delivery devices market size reached US$ 652.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,517.0 Million by 2028, exhibiting a growth rate (CAGR) of 33.6% during 2023-2028. What is Connected Drug Delivery Devices? Connected drug delivery devices represent a significant advancement in the field of medical technology, offering enhanced patient care and adherence to prescribed treatments. These devic...

According to IMARC Group’s latest report, titled “ Connected Drug Delivery Devices Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ”, the global connected drug delivery devices market size reached US$ 652.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,517.0 Million by 2028, exhibiting a growth rate (CAGR) of 33.6% during 2023-2028. Connected drug delivery devices refer to smart wireless electronic systems that support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors, and monitoring tools to provide instant feedback and education tools for personalized sufferer care. Connected drug delivery devices are convenient and save costs associated with clinic-based treatment. Consequently, they are widely utilized in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, clinically isolated syndrome, multipl...